Close
Creyon Bio, a leader in AI-enabled engineering of oligonucleotide-based medicines, has appointed Serge Messerlian and Shaquille Vayda to its Board of Directors. Their extensive backgrounds in life sciences and technology are expected to significantly contribute to Creyon's mission of transforming drug development. The appointments come as Creyon advances its innovative platform for creating oligonucleotide-based medicines.
Messerlian's experience spans various therapeutic areas, while Vayda brings a diverse skill set from technology and aerospace. Their insights will be crucial as Creyon aims to redefine the standards of drug engineering. The company is already making strides in clinical trials, showcasing the potential of its AI-driven approach.
• Creyon Bio focuses on AI-driven engineering of oligonucleotide-based medicines.
• New board members bring extensive experience in life sciences and technology.
Creyon Bio specializes in engineering these medicines for improved safety and efficacy.
Creyon Bio employs AI to revolutionize drug development processes.
This technology is integral to Creyon's platform for developing oligonucleotide-based medicines.
Creyon Bio is at the forefront of transforming drug discovery into drug engineering using AI.
Serge Messerlian, an Operating Partner at DCVC Bio, brings valuable expertise to Creyon's board.
Shaquille Vayda, a Principal at Lux Capital, adds significant experience to Creyon's leadership.
Business Insider 12month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
Key AI Highlights in this Article
Key AI Terms Mentioned in this Article
Companies Mentioned in this Article
